Announcements Trials

Browse Landscape

Phase

Phase 3 3 Phase NA 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 4 Carcinoma, Non-Small-Cell Lung 4 Esophageal Neoplasms 3 Stomach Neoplasms 2 Oropharyngeal Neoplasms 2 Multiple Myeloma 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tongue Neoplasms 1 Retinoblastoma 1 Recurrence 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Osteoporosis 1 Obesity 1 Neoplasms 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Lymphoma, Mantle-Cell 1

Interventions

Carboplatin 195 Cisplatin 117 Paclitaxel 107 Pemetrexed 106 Docetaxel 96 Gemcitabine 89 Radiotherapy 83 Erlotinib Hydrochloride 58 Bevacizumab 55 Etoposide 49 durvalumab 39 pembrolizumab 38 Nivolumab 31 Specimen Handling 30 Magnetic Resonance Spectroscopy 30 Irinotecan 27 Radiosurgery 26 osimertinib 24 Gefitinib 24 Drug Therapy 23 Vinorelbine 22 atezolizumab 20 Topotecan 20 Radiation 16 Cetuximab 16 Taxes 15 Surgical Procedures, Operative 14 Neoadjuvant Therapy 13 Filgrastim 13 Chemotherapy, Adjuvant 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lung Neoplasms × Observation × Clear all

NCT07472478 2026-03-16

GIVEN

Guangdong Provincial People's Hospital

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡